Literature DB >> 11479149

Follow-up of patients with epidemic poststreptococcal glomerulonephritis.

S W Pinto1, R Sesso, E Vasconcelos, Y J Watanabe, A M Pansute.   

Abstract

In 1998 there was a large outbreak of acute glomerulonephritis (GN) in Nova Serrana, Brazil, caused by group C Streptococcus zooepidemicus and linked to the consumption of contaminated cheese produced with unpasteurized milk. This study describes the follow-up of these patients after a mean of 2 years following the acute episode. Of 134 patients identified in 1998, 69 patients were reexamined and underwent measurements of blood pressure, 24-hour creatinine clearance, microalbuminuria (radioimmunoassay), and urine sediment analysis. Of the original group of 134 patients, 3 patients died in the acute phase and 5 patients (3.7%) required chronic dialysis. Of 69 patients reevaluated, 65 patients (94%) were adults (mean age, 39 +/- 2 [SE] years) and 47 patients (68%) were women. At the follow-up examination, we found arterial hypertension in 42% of subjects (27 of 64 subjects), serum creatinine levels greater than 1.2 mg/dL in 12% (10 of 68 subjects), reduced creatinine clearance (<80 mL/min/1.73 m(2)) in 30% (20 of 67 subjects, 2 of them on chronic dialysis therapy), and increased microalbuminuria (>20 microg/min) in 34% (22 of 65 subjects). Increased microalbuminuria and/or reduced creatinine clearance were detected in 48% of the subjects (31 of 65 subjects). Patients with microalbuminuria had greater diastolic blood pressure than those without microalbuminuria (mean, 98 +/- 4 versus 88 +/- 2 mm Hg; P = 0.02). In conclusion, after a mean of 2 years, patients with epidemic poststreptococcal GN caused by S zooepidemicus present a high rate of hypertension and frequent abnormalities of renal function, with some having reached end-stage renal disease. Longer follow-up will be important to define the prognosis of these patients.

Entities:  

Mesh:

Year:  2001        PMID: 11479149     DOI: 10.1053/ajkd.2001.26083

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

Review 1.  [Acute rheumatic fever (ARF) and poststreptococcal reactive arthritis (PSRA)--an update].

Authors:  R Keitzer
Journal:  Z Rheumatol       Date:  2005-06       Impact factor: 1.372

2.  A case of selective immunoglobulin M deficiency and autoimmune glomerulonephritis.

Authors:  Marina Antar; Jorge Lamarche; Alfredo Peguero; Alexander Reiss; Steven Cole
Journal:  Clin Exp Nephrol       Date:  2008-03-26       Impact factor: 2.801

3.  Changing epidemiology of acute post-streptococcal glomerulonephritis in Northeast Florida: a comparative study.

Authors:  Mohammad Ilyas; Asad Tolaymat
Journal:  Pediatr Nephrol       Date:  2008-03-29       Impact factor: 3.714

4.  Ten-Year Follow-up of Patients with Epidemic Post Infectious Glomerulonephritis.

Authors:  Sergio Wyton L Pinto; Gianna Mastroianni-Kirsztajn; Ricardo Sesso
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

Review 5.  A Comprehensive Review Study on Glomerulonephritis Associated With Post-streptococcal Infection.

Authors:  Mustafa A Alhamoud; Ibrahim Z Salloot; Shamim S Mohiuddin; Turki M AlHarbi; Faisal Batouq; Naif Y Alfrayyan; Ahmad I Alhashem; Mohammad Alaskar
Journal:  Cureus       Date:  2021-12-06

6.  Twenty-year Follow-up of Patients With Epidemic Glomerulonephritis due to Streptococcus zooepidemicus in Brazil.

Authors:  Sergio Wyton Pinto; Helbert do Nascimento Lima; Thalles Trindade de Abreu; Alba Otoni; Paulo Cesar Koch Nogueira; Ricardo Sesso
Journal:  Kidney Int Rep       Date:  2022-06-30

7.  Outbreak of Streptococcus equi subsp. zooepidemicus infections on the island of Gran Canaria associated with the consumption of inadequately pasteurized cheese.

Authors:  A Bordes-Benítez; M Sánchez-Oñoro; P Suárez-Bordón; A J García-Rojas; J A Saéz-Nieto; A González-García; I Alamo-Antúnez; A Sánchez-Maroto; M Bolaños-Rivero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.